Our UTI-Q technology is based on two mechanisms. The first mechanism is alternating the pH level and the other binds D-mannose to molecules of Escherichia coli (E.coli). These are then discharged with the urine.
This can used in a situation when a person is infected by E. coli. Our technology will then treat infection by reducing the growth of the microorganism in the urinary tract by alternating the pH level in the urine and the remaining E. coli bacteria will be discarded from the body, before they are able to colonize.
The technology relates to treatment of urinary tract infection (UTI) by using D-mannose as anti-adhesion agent in combination with increasing and decreasing pH in the urinary tract system of a subject suffering from UTI caused by E.coli.
E. coli has an adaptation time of 1-3 days. If the environment changes then the E- coli must adapt to the new environment and stop the proliferation.
Our Pilot Study indicates that it shows efficacy in uncomplicated UTI
Open pilot study performed during 2015 and 2016 at Vårdcentralen Ekenhälsan, Gothenburg.
Fifteen (15) women aged 7-88 years with recurring UTI participated. Patients were treated with UTI-Q for six days.
Download full study here